AnaptysBio, Inc. - Common Stock — Flux de trésorerie (NASDAQ:ANAB) | MetaTrader

Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques

Trimestriel Annuel

Flux de trésorerie liés aux activités d'exploitation -14.16 M-45.92 M-73.59 M-120.8 M-135.34 M19.7 M 4.48 M Flux de trésorerie liés aux activités d'investissement 94.47 M38.84 M-394.85 M144.75 M95.4 M228.03 M 248.17 M Flux de trésorerie liés aux activités de financement -879 K252.3 M44.02 M-59.3 M127.05 M-132.61 M -102.81 M Flux de trésorerie disponible -14.16 M-45.92 M-73.59 M-120.8 M-135.34 M19.61 M 4.41 M

Nouvelles

Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year?

Wall Street Analysts See a 38.75% Upside in AnaptysBio (ANAB): Can the Stock Really Move This High?

Forte Biosciences Stock: Targeting Celiac Disease (NASDAQ:FBRX)

AnaptysBio (ANAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

RCKT Stock Down on Q1 Earnings Miss, Kresladi Launch in Focus

Why These Four Biotech Stocks Prove That Follow-On Entries Still Pop Up In Stock Market Leaders

Nektar Q1 Earnings & Revenues Lag Estimates, Pipeline in Focus

PBYI Q1 Earnings & Sales Beat Estimates, 2026 Guidance Raised

Zoetis Q1 Earnings Lag Estimates, 2026 View Cut, Stock Down

TGTX Q1 Earnings Miss, Sales Rise Y/Y, Stock Up on Raised 2026 View

Mirum's Q1 Earnings & Revenues Beat Estimates, 2026 View Raised

AnaptysBio dévoile ses résultats en tant que société de redevances